NEW YORK (GenomeWeb News) – Advanced Biological Laboratories said today it signed a non-exclusive agreement with Roche Diagnostics for the promotion of certain ABL products.

In particular, the deal is aimed at promoting ABL's next-generation sequencing platform called DeepChek with Roche's NGS systems, the 454 GS Junior and 454 GS FLX+, for molecular virology. The deal covers Europe, the Middle East, Africa, and Latin America.

DeepChek is a solution for managing and analyzing NGS data.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

David Dobbs writes at Buzzfeed that genomics has delivered little on its promises.

In PNAS this week: co-evolutionary signatures of insect hosts and bacterial symbionts, distinct transcript isoforms of high-grade ovarian cancer, and more.

Adam Rutherford discusses genetic genealogy at the Guardian.

Portions of the US 21st Century Cures Act are raising some safety concerns.